Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib
- 14 March 2014
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 29 (5) , 1028-1029
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Sorafenib: from literature to clinical practiceAnnals of Oncology, 2013
- Epidemiology ofRhodotorula: An Emerging PathogenInterdisciplinary Perspectives on Infectious Diseases, 2012
- Cutaneous Rhodotorula Treated with Photodynamic TherapyDermatologic Surgery, 2012
- Rhodotorula mucilaginosa infection in Li-Fraumeni-like syndrome: a new pathogen in folliculitisBritish Journal of Dermatology, 2011
- Meta-analysis of dermatological toxicities associated with sorafenibClinical and Experimental Dermatology, 2011
- Emerging opportunistic yeast infectionsThe Lancet Infectious Diseases, 2011
- Kératoacanthomes multiples éruptifs induits par le sorafénibAnnales de Dermatologie et de Vénéréologie, 2009
- Infección por Rhodotorula. Revisión de 128 casosRevista Iberoamericana de Micologia, 2008
- Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylationLeukemia, 2008